IDH1 and glioblastoma: IDH status is a classical marker of GBM, and patients with IDH mutations tended to have a better survival (Reuss, Mamatjan & von Deimling, 2015; Burgenske, Yang & Sarkaria, 2019; Aldape, Zadeh & von Deimling, 2015).